Glaukos Corporation
GKOS
Rank in Stocks
#2116
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Share Price
$164.43
Last synced: 2026-10-16
Market Cap
$9.70B
Change (1 day)
-0.95%
Change (1 year)
88.63%
Country
US
Trade Glaukos Corporation (GKOS)
Category
Healthcare
Operating Margin for Glaukos Corporation (GKOS)
Operating Margin as of October 2026 TTM: -13.13%
According to Glaukos Corporation latest financial reports and stock price the company's current Operating Margin (TTM) is -13.13%. At the end of 2023 the company had an Operating Margin of -40.89%.
Operating Margin history for Glaukos Corporation from 2012 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -13.13% | -58.85% |
| 2024 | -31.91% | -21.96% |
| 2023 | -40.89% | 13.05% |
| 2022 | -36.17% | 69.18% |
| 2021 | -21.38% | -61.07% |
| 2020 | -54.92% | 158.81% |
| 2019 | -21.22% | 195.96% |
| 2018 | -7.17% | 401.40% |
| 2017 | -1.43% | -138.54% |
| 2016 | 3.71% | -125.84% |
| 2015 | -14.36% | -50.29% |
| 2014 | -28.89% | -57.38% |
| 2013 | -67.78% | -92.55% |
| 2012 | -909.76% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.03% | -101.30% |
US
|
|
| 17.86% | -101.36% |
IE
|
|
| 22.03% | -101.68% |
US
|
|
| 21.46% | -101.63% |
US
|
|
| 0.00% | - |
DE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.